2 clinics shown
Capital Mental Health operates a psychiatric practice in Chevy Chase on Wisconsin Avenue, providing outpatient mental health services for adults. The clinic focuses on psychiatric evaluations and medication management. Specific procedural treatments such as TMS or esketamine are not listed in available information; prospective patients should contact the practice to confirm current treatment offerings beyond standard psychiatric care.
Dr. Anca Zinnes operates a psychiatric practice in Chevy Chase on Wisconsin Avenue, affiliated with Johns Hopkins Medicine based on available directory information. The practice provides psychiatric evaluations and medication management for adults. Specific treatment modalities beyond standard psychiatric care—such as TMS, esketamine, or ketamine therapy—are not detailed in current listings and would require direct confirmation with the office.
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.